110 related articles for article (PubMed ID: 2844779)
1. In vivo and in vitro autoprocessing of human immunodeficiency virus protease expressed in Escherichia coli.
Giam CZ; Boros I
J Biol Chem; 1988 Oct; 263(29):14617-20. PubMed ID: 2844779
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of active form of HIV-1 protease from E.coli.
Wan M; Loh BN
Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.
Debouck C; Gorniak JG; Strickler JE; Meek TD; Metcalf BW; Rosenberg M
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8903-6. PubMed ID: 3321060
[TBL] [Abstract][Full Text] [Related]
4. Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli.
Mous J; Heimer EP; Le Grice SF
J Virol; 1988 Apr; 62(4):1433-6. PubMed ID: 2450209
[TBL] [Abstract][Full Text] [Related]
5. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.
Louis JM; McDonald RA; Nashed NT; Wondrak EM; Jerina DM; Oroszlan S; Mora PT
Eur J Biochem; 1991 Jul; 199(2):361-9. PubMed ID: 2070793
[TBL] [Abstract][Full Text] [Related]
6. An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity.
Graves MC; Lim JJ; Heimer EP; Kramer RA
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2449-53. PubMed ID: 3282230
[TBL] [Abstract][Full Text] [Related]
7. Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.
Strickler JE; Gorniak J; Dayton B; Meek T; Moore M; Magaard V; Malinowski J; Debouck C
Proteins; 1989; 6(2):139-54. PubMed ID: 2695927
[TBL] [Abstract][Full Text] [Related]
8. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.
Kräusslich HG; Ingraham RH; Skoog MT; Wimmer E; Pallai PV; Carter CA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):807-11. PubMed ID: 2644644
[TBL] [Abstract][Full Text] [Related]
9. Autoprocessing: an essential step for the activation of HIV-1 protease.
Wan M; Takagi M; Loh BN; Xu XZ; Imanaka T
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):569-73. PubMed ID: 8687402
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
[TBL] [Abstract][Full Text] [Related]
11. Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particles.
Weinheimer SP; McCann PJ; O'Boyle DR; Stevens JT; Boyd BA; Drier DA; Yamanaka GA; DiIanni CL; Deckman IC; Cordingley MG
J Virol; 1993 Oct; 67(10):5813-22. PubMed ID: 8396657
[TBL] [Abstract][Full Text] [Related]
12. Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.
Farmerie WG; Loeb DD; Casavant NC; Hutchison CA; Edgell MH; Swanstrom R
Science; 1987 Apr; 236(4799):305-8. PubMed ID: 2436298
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.
Darke PL; Leu CT; Davis LJ; Heimbach JC; Diehl RE; Hill WS; Dixon RA; Sigal IS
J Biol Chem; 1989 Feb; 264(4):2307-12. PubMed ID: 2644259
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bacterially expressed HIV protease activity determined by an in vitro cleavage assay with MuLV Pr65gag.
Bu M; Oroszlan S; Luftig RB
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):259-68. PubMed ID: 2543430
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Wu X; Liu H; Xiao H; Conway JA; Kappes JC
J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
Flexner C; Broyles SS; Earl P; Chakrabarti S; Moss B
Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
[TBL] [Abstract][Full Text] [Related]
17. Sequence, expression in Escherichia coli, and analysis of the gene encoding a novel intracellular protease (PfpI) from the hyperthermophilic archaeon Pyrococcus furiosus.
Halio SB; Blumentals II; Short SA; Merrill BM; Kelly RM
J Bacteriol; 1996 May; 178(9):2605-12. PubMed ID: 8626329
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency viral protease is catalytically active as a fusion protein: characterization of the fusion and native enzymes produced in Escherichia coli.
Boutelje J; Karlström AR; Hartmanis MG; Holmgren E; Sjögren A; Levine RL
Arch Biochem Biophys; 1990 Nov; 283(1):141-9. PubMed ID: 2241167
[TBL] [Abstract][Full Text] [Related]
19. Overproduction of human immunodeficiency virus type I reverse transcriptase in Escherichia coli and purification of the enzyme.
Saitoh A; Iwasaki H; Nakata A; Adachi A; Shinagawa H
Microbiol Immunol; 1990; 34(6):509-21. PubMed ID: 1699113
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase.
Tanese N; Prasad VR; Goff SP
DNA; 1988; 7(6):407-16. PubMed ID: 2462482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
